| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 9204931
[patent_doc_number] => 20140004108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products'
[patent_app_type] => utility
[patent_app_number] => 13/929036
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 303
[patent_figures_cnt] => 303
[patent_no_of_words] => 33394
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929036 | Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products | Jun 26, 2013 | Abandoned |
Array
(
[id] => 9107585
[patent_doc_number] => 20130280717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE'
[patent_app_type] => utility
[patent_app_number] => 13/922995
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8556
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922995
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922995 | METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE | Jun 19, 2013 | Abandoned |
Array
(
[id] => 12390900
[patent_doc_number] => 09964543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Selection of medicaments that modulate the function and activity of interleukin 13
[patent_app_type] => utility
[patent_app_number] => 13/921143
[patent_app_country] => US
[patent_app_date] => 2013-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20285
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921143
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921143 | Selection of medicaments that modulate the function and activity of interleukin 13 | Jun 17, 2013 | Issued |
Array
(
[id] => 9262156
[patent_doc_number] => 20130344085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/918755
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 51319
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918755
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/918755 | Anti-PCSK9 antibodies, formulations, dosing, and methods of use | Jun 13, 2013 | Issued |
Array
(
[id] => 10254938
[patent_doc_number] => 20150139935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'SLEEP APNEA TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/407786
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12573
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407786
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407786 | Sleep apnea treatment | Jun 13, 2013 | Issued |
Array
(
[id] => 9517764
[patent_doc_number] => 20140154257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 13/908750
[patent_app_country] => US
[patent_app_date] => 2013-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20121
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13908750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/908750 | Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents | Jun 2, 2013 | Abandoned |
Array
(
[id] => 12044582
[patent_doc_number] => 09822176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3'
[patent_app_type] => utility
[patent_app_number] => 14/400954
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 15350
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400954
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400954 | IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3 | May 28, 2013 | Issued |
Array
(
[id] => 10254944
[patent_doc_number] => 20150139941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/404197
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5850
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404197
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404197 | Combined therapy and prophylaxis for genital tract infections | May 28, 2013 | Issued |
| 13/903972 | Method for Analyzing Apoptosis Inducing Factor-2 | May 27, 2013 | Abandoned |
Array
(
[id] => 9602577
[patent_doc_number] => 20140199259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'STABILIZED LIQUID FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/903584
[patent_app_country] => US
[patent_app_date] => 2013-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11304
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/903584 | STABILIZED LIQUID FORMULATION | May 27, 2013 | Abandoned |
Array
(
[id] => 11778154
[patent_doc_number] => 09387189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Antibiotic composition comprising a chemotactic agent and a nutrient dispersion'
[patent_app_type] => utility
[patent_app_number] => 13/899980
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2428
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899980
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/899980 | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion | May 21, 2013 | Issued |
Array
(
[id] => 10255013
[patent_doc_number] => 20150140010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/402539
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12712
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402539 | METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS | May 21, 2013 | Abandoned |
Array
(
[id] => 9204930
[patent_doc_number] => 20140004107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'ST2 ANTIGEN BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/897096
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 56821
[patent_no_of_claims] => 154
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897096
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897096 | ST2 antigen binding proteins | May 16, 2013 | Issued |
Array
(
[id] => 10097155
[patent_doc_number] => 09133458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Methods for the treatment of hepatitis B and hepatitis D infections'
[patent_app_type] => utility
[patent_app_number] => 13/896421
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16281
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896421 | Methods for the treatment of hepatitis B and hepatitis D infections | May 16, 2013 | Issued |
Array
(
[id] => 10255010
[patent_doc_number] => 20150140008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/398053
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10544
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398053
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398053 | USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE | May 2, 2013 | Abandoned |
Array
(
[id] => 10608153
[patent_doc_number] => 09328174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-03
[patent_title] => 'Chemokine receptor binding polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/886530
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 5
[patent_no_of_words] => 45376
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886530
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/886530 | Chemokine receptor binding polypeptides | May 2, 2013 | Issued |
Array
(
[id] => 9338371
[patent_doc_number] => 20140065153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'Methods for Treating Hair Loss Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/886252
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 107
[patent_figures_cnt] => 107
[patent_no_of_words] => 74588
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886252
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/886252 | Methods for treating hair loss disorders | May 1, 2013 | Issued |
Array
(
[id] => 10911724
[patent_doc_number] => 20140314741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/865671
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3093
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865671
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865671 | Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases | Apr 17, 2013 | Abandoned |
Array
(
[id] => 9053988
[patent_doc_number] => 20130251702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'METHOD FOR SCREENING COMPOUNDS FOR TREATING SEPSIS TARGETING NOD2 SIGNALLING PATHWAY AND COMPOSITION FOR TREATING SEPSIS COMPRISING NOD2 SIGNALLING PATHWAY INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/848286
[patent_app_country] => US
[patent_app_date] => 2013-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 9972
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848286
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848286 | METHOD FOR SCREENING COMPOUNDS FOR TREATING SEPSIS TARGETING NOD2 SIGNALLING PATHWAY AND COMPOSITION FOR TREATING SEPSIS COMPRISING NOD2 SIGNALLING PATHWAY INHIBITORS | Mar 20, 2013 | Abandoned |
Array
(
[id] => 10281649
[patent_doc_number] => 20150166646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Methods and Compositions for Treating or Diagnosing Melanoma'
[patent_app_type] => utility
[patent_app_number] => 14/407607
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 24874
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407607
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407607 | Methods and Compositions for Treating or Diagnosing Melanoma | Mar 14, 2013 | Abandoned |